EV / EBITDA společnosti Panbela Therapeutics
Jaká je hodnota metriky EV / EBITDA společnosti Panbela Therapeutics?
Hodnota metriky EV / EBITDA společnosti Panbela Therapeutics Inc. je N/A
Jaká je definice metriky EV / EBITDA?
EV/EBITDA je podniková hodnota dělená EBITDA (zisk před odečtením úroků, daní, odpisů a amortizací). Měří nákladnost akcie a používá se k porovnání společností mezi sebou častěji než P/E ratio. Měří cenu, jakou investor zaplatí za pohyb hotovosti ve společnosti.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Panbela Therapeutics
Čemu se věnuje společnost Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Firmy s metrikou ev / ebitda podobnou společnosti Panbela Therapeutics
- Hodnota metriky EV / EBITDA společnosti Guild Esports Plc je N/A
- Hodnota metriky EV / EBITDA společnosti Delta Drone SA je N/A
- Hodnota metriky EV / EBITDA společnosti Canaccord Genuity je N/A
- Hodnota metriky EV / EBITDA společnosti Lordstown Motors je N/A
- Hodnota metriky EV / EBITDA společnosti Tesla Exploration je N/A
- Hodnota metriky EV / EBITDA společnosti DigiCrypts Blockchain Solutions je N/A
- Hodnota metriky EV / EBITDA společnosti Panbela Therapeutics je N/A
- Hodnota metriky EV / EBITDA společnosti Hapbee Technologies je N/A
- Hodnota metriky EV / EBITDA společnosti China Parenting Network je N/A
- Hodnota metriky EV / EBITDA společnosti X4 Pharmaceuticals je N/A
- Hodnota metriky EV / EBITDA společnosti Delta Drone SA je N/A
- Hodnota metriky EV / EBITDA společnosti Diablo Resources Ltd je N/A
- Hodnota metriky EV / EBITDA společnosti cbdMD Inc je N/A